Centiva Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Centiva Capital’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	250,000 +100,000	+67%	+$1.07M	0.02%	380
2026 Q1	$1.58M	Hold	150,000	–	–	0.01%	484
2025 Q4	$1.57M	Hold	150,000	–	–	0.01%	478
2025 Q3	$1.55M	Hold	150,000	–	–	0.01%	425
2025 Q2	$1.54M	Buy	+150,000	New	+$1.52M	0.03%	436

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.74% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.56% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

Centiva Capital's TDAC Position: Q2 2026 in Review

Centiva Capital increased its Translational Development Acquisition Corp (TDAC) stake by 67% in Q2 2026, buying an estimated $1.07M and bringing the position to 250,000 shares worth $2.67M. The position accounts for 0.02% of the portfolio, ranked #380.

Centiva Capital first reported a position in TDAC in Q2 2025 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Centiva Capital held 250,000 shares of Translational Development Acquisition Corp worth $2.67M as of Q2 2026.
Centiva Capital bought 100,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.07M.
Translational Development Acquisition Corp made up 0.02% of Centiva Capital's portfolio in Q2 2026, its #380 holding.
Centiva Capital first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 5 quarters since.
29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.